Missouri · 2026 Regular Session · Bill

SB 1724: Makes xylazine a Schedule III controlled substance

In committee Last action May 7, 2026: Second Read and Referred S Judiciary and Civil and Criminal Jurisprudence Committee

Plain-language summary

SB 1724 is a bill introduced in the Missouri Senate on February 25, 2026. According to its official title, it concerns: Makes xylazine a Schedule III controlled substance. Primary sponsor: Justin Brown (Republican). Most recent recorded action (May 7, 2026): Second Read and Referred S Judiciary and Civil and Criminal Jurisprudence Committee.

Sponsors

Primary sponsor: Justin Brown (Republican).